Ashby, MA, United States of America

Michael Madden

This inventor holds 2 USPTO granted patents. Top assignee: C. R. Bard, Inc.. Active years: 1993-1994.


% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 320(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Madden - Innovator in Angioplasty Technology

Introduction

Michael Madden is a notable inventor based in Ashby, MA (US), recognized for his contributions to the field of medical technology, particularly in angioplasty systems. With a total of 2 patents, Madden has developed innovative solutions aimed at improving the identification and treatment of atherosclerotic plaque in blood vessels.

Latest Patents

Madden's latest patents include an angioplasty system that features advanced means for the identification of atherosclerotic plaque. This system employs fluorescence analysis to identify noncalcified plaque and utilizes calcium photoemission analysis for detecting calcified plaque. The innovative approach allows for the distinction between calcium photoemission and potential defects in the optical fibers used for laser energy delivery. Another significant patent is a device designed for laser angioplasty, which incorporates a high-power laser and a flexible catheter equipped with circumferentially arrayed optical fibers. This apparatus is capable of removing atherosclerotic plaque deposits while providing diagnostic capabilities through an ultrasonic transducer.

Career Highlights

Michael Madden is currently associated with C. R. Bard, Inc., where he continues to advance his research and development efforts in medical devices. His work has significantly impacted the field of vascular interventions, enhancing the efficacy and safety of angioplasty procedures.

Collaborations

Madden has collaborated with esteemed colleagues, including Glenn S. Baker and Michael G. Dumont, contributing to a dynamic team focused on innovation in medical technology.

Conclusion

Michael Madden's contributions to angioplasty technology exemplify the spirit of innovation in the medical field. His patents reflect a commitment to improving patient outcomes through advanced medical devices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…